Maps Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.50 Cr
as on 24-10-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 Cr
as on 24-10-2024
- Satisfied Charges ₹ 5.62 Cr
as on 24-10-2024
- Revenue 2.77%
(FY 2023)
- Profit -20.12%
(FY 2023)
- Ebitda -7.57%
(FY 2023)
- Net Worth 9.98%
(FY 2023)
- Total Assets 10.47%
(FY 2023)
About Maps Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹5.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rupeshkumar Kotadia and Krunalbhai Kotadiya serve as directors at the Company.
- CIN/LLPIN
U24117GJ2001PTC039923
- Company No.
039923
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maps Laboratories Private Limited offer?
Maps Laboratories Private Limited offers a wide range of products and services, including Blood Pressure Medicine, Azilsartan Medoxomil Tablet.
Who are the key members and board of directors at Maps Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupeshkumar Kotadia  | Director | 28-Aug-2001 | Current |
| Krunalbhai Kotadiya | Director | 10-Oct-2008 | Current |
Financial Performance of Maps Laboratories.
Maps Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.77% increase. The company also saw a substantial fall in profitability, with a 20.12% decrease in profit. The company's net worth moved up by a moderate rise of 9.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maps Laboratories?
In 2023, Maps Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maps Granito Private LimitedActive 8 years 21 daysRupeshkumar Kotadia and Krunalbhai Kotadiya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Apr 2013 | ₹4.50 Cr | Open |
Dena Bank Creation Date: 26 Feb 2010 | ₹4.00 Cr | Satisfied |
State Bank Of India Creation Date: 15 Jan 2002 | ₹4.99 M | Satisfied |
How Many Employees Work at Maps Laboratories?
Unlock and access historical data on people associated with Maps Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maps Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maps Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
